Maxillary anterior ridge augmentation with recombinant human bone morphogenetic protein 2

Ryan K. Edmunds, Brian L Mealey, Michael P Mills, Daniel S. Thoma, John Schoolfield, David L Cochran, Jim Mellonig

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Abstract

No human studies exist on the use of recombinant human bone morphogenetic protein 2 (rhBMP-2) on an absorbable collagen sponge (ACS) as a sole graft material for lateral ridge augmentation in large ridge defect sites. This series evaluates the treatment outcome of maxillary anterior lateral ridge augmentation with rhBMP-2/ACS. Twenty patients were treated with rhBMP-2/ACS and fixation screws for space maintenance. Cone beam volumetric tomography measurements were used to determine gain in ridge width, and a bone core biopsy was obtained. The mean horizontal ridge gain was 1.2 mm across sites, and every site gained width.

Original languageEnglish (US)
Pages (from-to)551-557
Number of pages7
JournalThe International journal of periodontics & restorative dentistry
Volume34
Issue number4
DOIs
StatePublished - Jul 1 2014

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Maxillary anterior ridge augmentation with recombinant human bone morphogenetic protein 2'. Together they form a unique fingerprint.

Cite this